A detailed history of Clear Street LLC transactions in Bio Affinity Technologies, Inc. stock. As of the latest transaction made, Clear Street LLC holds 100 shares of BIAF stock, worth $96. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Holding current value
$96
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.32 - $2.82 $132 - $282
100 New
100 $0
Q1 2024

May 13, 2024

BUY
$1.42 - $3.0 $142 - $300
100 New
100 $0

Others Institutions Holding BIAF

About bioAffinity Technologies, Inc.


  • Ticker BIAF
  • Exchange
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 2,727,580
  • Market Cap $2.62M
  • Description
  • bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...
More about BIAF
Track This Portfolio

Track Clear Street LLC Portfolio

Follow Clear Street LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Street LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Street LLC with notifications on news.